Tenderwize
Back to tender search

Arzneimittel-Rabattverträge zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

AOK NordWest - Die Gesundheitskasse·Dortmund, Germany·Deadline Jul 26, 2026 · 19 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel-Rabattverträge zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

The buyer may conclude exclusive discount agreements during the contract period, which will suspend these Open-House co...

No estimate of expected volume or value is provided; actual business may be minimal or zero.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Sep 2026
  • Supply of pharmaceutical products for multiple active substances including Bexaroten, Budesonid, Ciclopirox, Clonidin, Dornase alfa, Febuxostat, Filgrastim, Follitropin alfa, Glyceroltrinitrat, Irbesartan & Hydrochlorothiazid, Miglustat, Naproxen, Olanzapin (excluding solid oral forms), Oxycodon & Naloxon, Rasagilin, Silodosin, Sorafenib, Tapentadol (excluding retard tablets), Telmisartan, Timolol & Latanoprost, Triamteren & Hydrochlorothiazid.
  • Conclusion of discount agreements under §130a(8) SGB V
Show full summary

This is an Open-House procedure for pharmaceutical discount agreements (Rabattverträge) under §130a(8) SGB V for multiple active substances. The buyer, AOK NordWest, offers any eligible pharmaceutical company the opportunity to conclude a discount agreement under uniform conditions. The procedure is not subject to EU procurement law but published voluntarily for transparency. There is one lot covering all listed active substances. Contracts have a maximum duration of 24 months starting from 01.10.2024. No estimated value is provided. Submission is via email and the deadline is 2026-08-03.

Risks

The buyer may conclude exclusive discount agreements during the contract period, which will suspend these Open-House co...

No estimate of expected volume or value is provided; actual business may be minimal or zero.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Tenderer must be a pharmaceutical entrepreneur as defined in §4(18) AMG for the offered medicinal products

Eligibility

  • Eligibility must be maintained for the entire contract duration

Administrative

  • Submission via email only (no electronic submission allowed)

Requirements may be incomplete.

Buyer

Name

AOK NordWest - Die Gesundheitskasse

Location

Dortmund, DEU

Website

www.aok.de

Identifier

DE124159739

Activity

Health

Lots (1)

LOT-0001

Arzneimittel-Rabattverträge zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

One lot covering all listed active substances. Open-House procedure: all eligible pharmaceutical companies can conclude a discount agreement under uniform conditions. Maximum contract duration 24 months from earliest start 01.10.2024.

SuppliesEU fundedElectronic submission

Location

Hagen, Germany

Duration

Sep 2024 - Sep 2026

Category

Pharmaceutical products

Deadline

Deadline Aug 03, 2026

Procurement Details

Publication date
11 Aug 2024
Notice type
Contract notice — standard
Languages
German

Reference metadata

Notice subtype
16
Notice version
1
Legal basis
32014L0024

Reference IDs

Tender ID
483304-2024

Documents (1)

Similar tenders